Ipsen gains exclusive global rights, outside of Greater China, for development, manufacturing and commercialization of SIM0613, a LRRC15-targeting antibody-drug conjugateSIM0613 is optimally designed ...

A novel polycyclic aromatic hydrocarbon derivative hole selective material (4PADNC) has been designed to optimize hole ...

Radionuclide drug conjugates (RDCs) have emerged as transformative agents that integrate diagnosis and therapy into a single ...

Earlier in December 2025, Biohaven Ltd. reported new clinical safety and efficacy data at the ESMO Immuno-Oncology Congress for its Trop2-directed antibody drug conjugate BHV-1510 combined with ...

PeptiDream Inc., a public Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587), announced the achievement of a preclinical development milestone in ...

The U.S. childhood immunization schedule, the grid of colored bars pediatricians share with parents, recommends a set of ...

TALLAHASSEE – Florida’s surgeon general wants to do away with all state vaccine mandates. But the first step in his plan ...

Learn more about whether Travere Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Southwest Florida hospitals are experiencing an increase in patients due to flu and tourist seasons. Health officials advise using walk-in clinics for non-urgent conditions to keep emergency rooms ...

The combined Company will move forward as Decoy Therapeutics, Inc. and trade on the NASDAQ Stock Market under the ticker “DCOY” effective in ...